★ "What Worked For Me" Outcome Report @MigraineFreeDays_GA • 45-59F • 125mcg Levothyroxine / 10mcg • Week 28
▲ 37 Helpful • 2 Peer Replies

Bedtime Levo + Morning Liothyronine Split (28 wks update): I'm a 48-year-old woman with hypothyroidism and persistent fatigue/brain fog despite TSH 2 — what worked for others here?

I'm a 48-year-old woman with hypothyroidism and persistent fatigue/brain fog despite TSH 2.1 mIU/L on 125mcg levothyroxine. My endocrinologist added liothyronine 5mcg twice daily (morning and early afternoon) and we switched levothyroxine to bedtime dosing. New protocol: levothyroxine 125mcg at 10pm (3 hours post-dinner), liothyronine 5mcg at 6am and 1pm, selenium 200mcg at lunch, iron bisglycinate 25mg + calcium citrate 500mg at 6pm dinner. After 12 weeks: TSH 1.4 mIU/L, free T3 rose from 2.8 to 3.6 pg/mL (range 2.0-4.4), energy dramatically improved, brain fog 80% resolved. Key insight: splitting liothyronine doses avoided afternoon crashes, and bedtime levo eliminated morning coffee conflicts.

⚕ Pinned FDA / NIH / PubMed Clinical Context • Karim El-Sayed — Literature & Label Auditor

FDA DailyMed labels for liothyronine (Cytomel) note its 2.5-hour half-life vs. levothyroxine's 7-day half-life, making split dosing (BID or TID) physiologically rational for stable T3 levels. NIH-funded studies show 10-15% of hypothyroid patients benefit from combination T4/T3 therapy when free T3 remains low-normal despite adequate TSH suppression on levothyroxine monotherapy.

Verified Peer Replies (2)

@PeachtreeRunner_GA • Age 45-59 • Week 36 • Combination T4/T3

This is almost identical to my protocol! I do 100mcg levo at bedtime, liothyronine 5mcg at 7am and 2pm. The split dosing was life-changing—no more 3pm energy crash. My free T3 went from 2.6 to 3.4 pg/mL and I finally feel normal. Also doing selenium 200mcg daily; TPO antibodies dropped 40% in 6 months.

@GraniteHiker_NH • Verified Cohort Member • Week 21

Excellent documentation of combination therapy. The 2012 European Thyroid Association guidelines note that 10-15% of patients have persistent symptoms despite normalized TSH on levothyroxine monotherapy, often due to impaired T4→T3 conversion (DIO2 polymorphisms). Your free T3 rise (2.8→3.6 pg/mL) and symptom resolution validate the protocol. Bedtime levothyroxine + split-dose liothyronine is increasingly supported in endocrinology literature for refractory cases.

Add Your Experience or Answer (Pseudonymous @Handle • Zero-PHI)

More Active Discussions in Diabetes, Thyroid & A1C